Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2910688 | 0.85 | LMNA (0.47) | POLBMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3749011 | 0.83 | POLB (0.42) | POLBGAACA12CA1CA2 | |
| SCHEMBL2474178 | 0.76 | POLB (0.60) | POLBGAACA12CA1CA2 | |
| SCHEMBL17451136 | 0.74 | POLB (0.58) | POLBGAACA12CA1CA2 | |
| SCHEMBL11802485 | 0.73 | POLB (0.68) | POLBGAACA12CA1CA2 | |
| SCHEMBL3364492 | 0.72 | KMT2A (0.49) | POLBKMT2ASMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL3365341 | 0.72 | HPGD (0.47) | GAAMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL3367290 | 0.72 | KMT2A (0.49) | POLBKMT2ASMN1; SMN2ALDH1A1KDM4E | |
| SCHEMBL3366856 | 0.72 | HPGD (0.47) | GAAMEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL8883302 | 0.71 | MAPT (0.46) | POLBGAACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2160383-B1 | N, N',N''-TRIMETHYL-N, N', N''-TRIS(METHOXYCARBONYL)-MELAMINE DERIVATIVES AND SIMILAR TRIAZINE DERIVATIVES FOR AS CROSS-LINKERS AND/OR BINDERS IN COATING COMPOUNDS, PAINTS, INKS, COMPOSITE MATERIALS AND LAMINATES | BOREALIS AGROLINZ MELAMINE (AT) | 2016-03-09 | — | — | EP | disclosed |
| US-8569423-B2 | Triazine derivatives and a method for their production | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2013-10-29 | — | — | US | disclosed |
| US-8569423-B2 | Triazine derivatives and a method for their production | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2013-10-29 | — | — | US | disclosed |
| US-20100292409-A1 | Triazine Derivatives and a Method for Their Production | BOREALIS AGROLINZ MELAMINE GMBH (AU) | 2010-11-18 | — | — | US | disclosed |
| US-20100292409-A1 | Triazine Derivatives and a Method for Their Production | BOREALIS AGROLINZ MELAMINE GMBH (AU) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292409-A1 | Triazine Derivatives and a Method for Their Production | CYP3A5, CYP4Z1, IL5 | POLB 3342/4885GAA 844/4885CA12 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.